What severe skin reactions have been reported with doravirine-containing regimens such as Delstrigo?

Severe cutaneous adverse reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported during postmarketing experience with doravirine-containing regimens such as Delstrigo.